FDA Investigator Nirjal Bhattarai

Nirjal Bhattarai has inspections in 1 countries as of 06 Dec 2023. Nirjal Bhattarai has collaborated with a combinined 468 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Nirjal Bhattarai's Documents

Publish Date Document Type Title
October, 2020 EIR Juno Therapeutics, Inc. - EIR, 2020-10-16
October, 2020 FDA 483 Response Juno Therapeutics, Inc. - Form 483R, 2020-11-05
October, 2020 FDA 483 Juno Therapeutics, Inc. - Form 483, 2020-10-16
December, 2023 FDA 483 Carsgen Therapeutics Corporation - Form 483, 2023-12-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more